Exodus Point Capital Management, LP Abbott Laboratories Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 41,621 shares of ABT stock, worth $4.33 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
41,621
Previous 59,208
29.7%
Holding current value
$4.33 Million
Previous $5.73 Million
17.49%
% of portfolio
0.04%
Previous 0.05%
Shares
17 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.2 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.8 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.74 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.77 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.3 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...